Showing results (1021-1030 of 1,034) with videos related to

Sort By:
Pageof 104
American Journal of Physiology. Lung Cellular and Molecular Physiology|September 11, 2012
Annexin V decreases PS-mediated macrophage efferocytosis and deteriorates elastase-induced pulmonary emphysema in miceS Yoshida, N Minematsu, S Chubachi, et al.
Gastrointestinal Endoscopy|May 27, 1999
Interobserver and intraobserver variation in endoscopic assessment of GERD using the "Los Angeles" classificationM Kusano, K Ino, T Yamada, et al.
Therapeutic Apheresis : Official Journal of the International Society for Apheresis and the Japanese Society for Apheresis|May 4, 1999
Plasmapheresis in the treatment of rapidly progressive glomerulonephritisT Harada, Y Ozono, M Miyazaki, et al.
Oncology Reports|April 18, 2000
Identification of a 7-cM region of frequent allelic loss on chromosome band 16p13.3 that is specifically associated with anaplastic thyroid carcinomaM Kadota, Y Tamaki, I Sakita, et al.
Revista Da Sociedade Brasileira De Medicina Tropical|January 1, 1995
[Frequency of intestinal helminth eggs in public restrooms in Sorocaba, SP]T Aidar Sobrinho, L M Coelho, S M de Oliveira, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 26, 1999
Enhanced interstitial expression of caldesmon in IgA nephropathy and its suppression by glucocorticoid-heparin therapyY Ando, T Moriyama, K Oka, et al.
The British Journal of Dermatology|August 19, 2011
Effects of bosentan on nondigital ulcers in patients with systemic sclerosisT Taniguchi, Y Asano, M Hatano, et al.
Lupus|July 13, 2019
Delayed lupus nephritis in the course of systemic lupus erythematosus is associated with a poorer treatment response: a multicentre, retrospective cohort study in JapanM Nakano, K Kubo, Y Shirota, et al.
International Journal of Oncology|May 26, 1999
Comparative genomic hybridization defines frequent loss on 16p in human anaplastic thyroid carcinomaY Komoike, Y Tamaki, I Sakita, et al.
Investigational New Drugs|December 16, 2014
Phase II trial of combination therapy of gemcitabine plus anti-angiogenic vaccination of elpamotide in patients with advanced or recurrent biliary tract cancerMasato Matsuyama, H Ishii, J Furuse, et al.
Pageof 104